Difference between revisions of "Part:BBa K3034006"
Line 2: | Line 2: | ||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K3034006 short</partinfo> | <partinfo>BBa_K3034006 short</partinfo> | ||
+ | |||
+ | ===Usage and Biology=== | ||
+ | |||
+ | This part is a ciprofloxacin resistance cassette. It contains a strong promoter J23119(<html><a href='https://parts.igem.org/Part:BBa_J23119'>BBa_J23119</a></html>), RBS(<html><a href='https://parts.igem.org/Part:BBa_K1725309'>BBa_K1725309</a></html>), ciprofloxacin resistance gene ''qnrS1'' and a terminator(<html><a href='https://parts.igem.org/Part:BBa_B1006'>BBa_B1006</a></html>)(fig.1). | ||
+ | |||
+ | Ciprofloxacin resistance gene ''qnrS1'' is first found in Gram-negative strains. It's one of the plasmid-mediated quinolone resistance genes and it encodes pentapeptide duplicates of about 200 amino acids. These proteins can produce quinolone resistance through two different mechanisms of action. One is decreasing the number of quinolone target sites by reducing DNA binding to helicase or topoisomerase IV. The other one is to inhibit the binding of quinolone to enzymes by binding these proteins to helicase or topoisomerase. | ||
+ | |||
+ | [[File:T-UESTC-China-Framework.png|500px|thumb|center|'''fig.1''' The Framework of <html><a href='https://parts.igem.org/Part:BBa_K3034006'>BBa_K3034006</a></html>.]] | ||
− | |||
− | |||
− | |||
− | |||
<span class='h3bb'>Sequence and Features</span> | <span class='h3bb'>Sequence and Features</span> | ||
<partinfo>BBa_K3034006 SequenceAndFeatures</partinfo> | <partinfo>BBa_K3034006 SequenceAndFeatures</partinfo> |
Revision as of 03:32, 2 October 2019
Ciprofloxacin resistance cassette
Usage and Biology
This part is a ciprofloxacin resistance cassette. It contains a strong promoter J23119(BBa_J23119), RBS(BBa_K1725309), ciprofloxacin resistance gene qnrS1 and a terminator(BBa_B1006)(fig.1).
Ciprofloxacin resistance gene qnrS1 is first found in Gram-negative strains. It's one of the plasmid-mediated quinolone resistance genes and it encodes pentapeptide duplicates of about 200 amino acids. These proteins can produce quinolone resistance through two different mechanisms of action. One is decreasing the number of quinolone target sites by reducing DNA binding to helicase or topoisomerase IV. The other one is to inhibit the binding of quinolone to enzymes by binding these proteins to helicase or topoisomerase.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 7
Illegal NheI site found at 30 - 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 36
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]